title: Synaptic targeting and functional modulation of GluK1 kainate receptors by the auxiliary neuropilin and tolloid-like (NETO) proteins.
abstract: Auxiliary proteins modify the biophysical function and pharmacological properties of ionotropic glutamate receptors and likely are important components of receptor signaling complexes in vivo. The neuropilin and tolloid-like proteins (NETO) 1 and NETO2, two closely related CUB domain-containing integral membrane proteins, were identified recently as auxiliary proteins that slowed GluK2a kainate receptor current kinetics without impacting receptor membrane localization. Here we demonstrate that NETO2 profoundly slows the desensitization rate of GluK1 kainate receptors, promotes plasma membrane localization of transfected receptors in heterologous cells and rat hippocampal neurons, and targets GluK1-containing receptors to synapses. Conversely, the closely related protein NETO1 increases the rate of GluK1 receptor desensitization. Incorporation of NETO proteins into kainate receptor-signaling complexes therefore extends the temporal range of receptor gating by over an order of magnitude. The presence of these auxiliary proteins could underlie some of the unusual aspects of kainate receptor function in the mammalian CNS.
authors: Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
authors: Bryan A
authors: BA
authors: Copits
authors: John S
authors: JS
authors: Robbins
authors: Shanti
authors: S
authors: Frausto
authors: Geoffrey T
authors: GT
authors: Swanson
references: Nat Neurosci. 1998 Oct;1(6):470-8
references: 10196544
references: J Physiol. 1998 Dec 15;513 ( Pt 3):639-46
references: 9824706
references: Neuron. 1990 Sep;5(3):255-66
references: 2169266
references: Gene. 2002 Mar 20;286(2):223-31
references: 11943477
references: J Neurosci. 2003 Jan 15;23(2):422-9
references: 12533602
references: PLoS Biol. 2009 Feb 24;7(2):e41
references: 19243221
references: Nature. 2004 Jan 29;427(6973):451-7
references: 14749834
references: Mol Cell Neurosci. 2007 Apr;34(4):539-50
references: 17254796
references: Nature. 2000 Dec 21-28;408(6815):936-43
references: 11140673
references: Br J Pharmacol. 2010 Jul;160(6):1417-29
references: 20590632
references: Nature. 1997 Jul 10;388(6638):182-6
references: 9217159
references: Mol Cell Neurosci. 2007 Feb;34(2):219-30
references: 17174564
references: Nat Genet. 1998 Aug;19(4):340-7
references: 9697694
references: Nature. 1998 Apr 9;392(6676):601-5
references: 9580260
references: J Neurosci. 2004 Mar 10;24(10):2506-15
references: 15014126
references: Trends Neurosci. 1997 Jan;20(1):9-12
references: 9004411
references: Nature. 1998 Jul 9;394(6689):192-5
references: 9671304
references: J Neurosci. 1999 Jan 15;19(2):653-63
references: 9880586
references: J Neurosci. 2007 Sep 26;27(39):10423-33
references: 17898214
references: Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):485-90
references: 15630087
references: J Biol Chem. 2009 May 22;284(21):14503-12
references: 19342380
references: J Neurosci. 2000 Jan 1;20(1):196-205
references: 10627597
references: Pharmacol Rev. 2010 Sep;62(3):405-96
references: 20716669
references: Nat Neurosci. 1998 Oct;1(6):479-86
references: 10196545
references: Neuron. 1995 May;14(5):1009-17
references: 7748549
references: Neuron. 2002 Jul 3;35(1):147-59
references: 12123615
references: Neuron. 1993 Dec;11(6):1069-82
references: 7506043
references: Brain Res Dev Brain Res. 2004 Oct 15;153(1):135-42
references: 15464227
references: Curr Pharm Des. 2007;13(15):1597-605
references: 17504152
references: Neuron. 2009 Feb 12;61(3):385-96
references: 19217376
references: J Biol Chem. 2003 Dec 26;278(52):52700-9
references: 14527949
references: Nature. 1997 Jul 10;388(6638):179-82
references: 9217158
references: Neuron. 2009 Sep 24;63(6):818-29
references: 19778510
references: Nature. 2004 Sep 30;431(7008):578-82
references: 15457263